BackMillendo Therapeutics Overview

Millendo Therapeutics Other Current Assets

Track Millendo Therapeutics's other current assets ($920K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$918000.00
↑ 11.54% YoYΔ $95000.00 vs prior year quarter

Peer average / median

Loading

Millendo Therapeutics Other Current Assets History

Loading

Millendo Therapeutics vs. peers: Other Current Assets Comparison

Loading

Millendo Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Millendo Therapeutics (MLND) FAQ

Millendo Therapeutics (MLND) currently reports a other current assets of $920K as of June 2026. That compares with $820K in the prior-year period — up 11.5% year over year. Use the charts on this page to explore Millendo Therapeutics's other current assets history and peer comparisons.

Millendo Therapeutics's other current assets increased from $820K to $920K — a 11.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Millendo Therapeutics reported $920K in other current assets as of June 2026. That compares with $820K in the prior-year period — up 11.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $920K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Millendo Therapeutics, and consider following MLND for alerts when major investors trade the stock.

Millendo Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $920K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MLND with unrelated industries.